clinical diagnostics News
-
RAMCON now disbribute Beckman Coulter Clinical Diagnostics products
We are happy to announce that RAMCON will be adding the clinical diagnostics solutions from Beckman Coulter to our product portfolio, starting January 1 2021! RAMCON has been a long time Beckman Coulter partner, and we are pleased to consolidate our business relationship even further. We are looking forward to bring our high level of knowledge and experience in to play and strengthen the market ...
By RAMCON
-
CardioWise Named Rising Star at the UCSF Health Awards
The University of California San Francisco (UCSF) Health Awards named CardioWise, Inc. as a Rising Star in the Clinical Diagnostic Tool category. The awards highlight the health tech industry, showcasing the best new products and technologies in digital health and life sciences. To see video, please click ...
-
Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics
Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS analyzers. Through this agreement, Ortho Clinical Diagnostics customers will have complete access to MAS third-party ...
-
Times of San Diego - UCSD Biotech Entrepreneur Wins at UC Innovation Summit
The University of California recently awarded UC San Diego entrepreneur Jason McKeown for his wearable weight loss technology company Neurovalens, UC announced Monday. McKeown was one of 12 finalists in the third annual UC Entrepreneur Pitch Competition. Six early-stage biotechnology startups and six late-stage biotech businesses were selected to present their pitches at last week’s 2019 ...
-
New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories
Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic laboratories to leverage a comprehensive platform for developing sensitive and reliable laboratory ...
-
Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies, for $24.68 per share of common stock using a combination of cash and newly issued shares in ...
-
CRP Presentation 2015
HORIBA Medical Thailand team had opportunity to present CRP and Microsemi CRP on February 12th 2015. This meeting, which was hosted at Phaholpolpayuhasena Hospital, was the first in a series of CRP Promotion in Thai Market. This workshop brought together delegates and doctors from Kanchanaburi Province. A brief information on the device was presented by Mr. Bedi, our Senior Application ...
-
Amerigo Scientific Introduces the Launch of Polystreptavidin 350
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA. Diagnosis is a key enabler of universal health coverage and the first line of defense against the spread of many diseases. From rapid treatment and combating ...
-
Intrasense signs a historic contract with Brazilian medical technology leader MV
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina. Intrasense solutions gain strong visibility in Latin America MV, a leading provider of ...
By Intrasense
-
CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service
CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities. Viruses, being the most abundant entities on our planet, play a pivotal ...
By CD Genomics
-
Exploring next steps in cancer precision diagnostics using transcriptomics
While DNA is largely identical in all cells, RNA fluctuates considerably both in presence and relative concentrations. The variation reflects the underlying cause of a cell’s character and thus RNA analysis gives a more accurate view of the state cells are in compared to DNA analysis. Gene expression levels are important to analyse, and quantitative RNA sequencing is the most informative ...
By Qlucore AB
-
Creative Proteomics Introduces Innovative Absolute Quantification (AQUA) Service for Precise Protein Quantification Analysis
Creative Proteomics, a leading global provider of proteomics services, is proud to announce the launch of its innovative Absolute Quantification (AQUA) service, offering scientists a highly accurate solution for protein quantification analysis. This groundbreaking service will play a crucial role in life science research, drug development, and clinical diagnostics. Absolute Quantification (AQUA) ...
-
TeraRecon Expands Distribution to Brazil with KLAS Leading PACS provider, Pixeon
Advanced visualization and artificial intelligence leader, TeraRecon, today announced partner expansion in the Brazilian market with KLAS leading PACS provider, Pixeon. Pixeon will be the primary distribution partner for TeraRecon in Brazil and surrounding regions. TeraRecon's multi-specialty advanced visualization solution, Intuition Titanium, will be fully integrated with Pixeon's PACS, known ...
-
Agplus Appoints New Chief Scientific Officer
Ahead of their attendance at this year’s MEDICA event, AgPlus have appointed a new Chief Scientific Officer, Dr Nic Christofides, who has vast experience of finalising late stage clinical assays to ensure commercial success. Of Cypriot descent, Dr Christofides started his career in 1973 at Hammersmith Hospital, London, as a research assistant where he developed immunoassay for Oestriol ...
-
CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service
RNA-Solutions is a platform for revolutionary research in RNA, targeting coding and non-coding RNAs with different physiological functions. Scientists at CD Genomics are ready to help detect various types of RNAs via meticulous and integrative approaches. Powered by the Illumina, Pacbio SMRT, and Nanopore sequencing platforms, CD Genomics offers services performed by de novo and reference-based ...
By CD Genomics
-
Kephera Diagnostics’ new CLIA laboratory launches testing for COVID-19 antibodies
Kephera Diagnostics announced today that it has been approved as a CLIA certified laboratory by the Massachusetts Dept of Public Health and the U.S. Centers for Medicare and Medicaid, and is now offering COVID-19 antibody testing in Massachusetts and 44 other states. Kephera will use an ELISA (Enzyme-Linked Immunosorbent Assay) test that it developed in-house, which is based on the ...
-
ELITechGroup Microbiology releases a new rapid test to detect resistance to polymyxins
Among the most clinically significant multidrug-resistantbacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usuallyremain susceptible to polymyxins, interest in this old class of antibiotics has been recentlyrenewed. However, the increasing use of colistin explains why Enterobacterial strains resistantto colistin are increasingly reported worldwide. Currently ...
By ELITechGroup
-
Bruker Appoints Robert Rosenthal to Board of Directors
Bruker Corporation (NASDAQ:BRKR) today announced that it has appointed Dr. Robert Rosenthal to its Board of Directors, effective immediately. Dr. Rosenthal currently serves as Chief Executive Officer and as a director for Taconic Biosciences, Inc., a privately-held provider of research models for the pharmaceutical and biotech industry, a position he has held since joining Taconic Biosciences in ...
-
Curasight expands its strategy and strengthen its position as a theranostic company
Curasight A / S ("Curasight" or "The Company") announces today that it is expanding and accelerating its clinical programs with two additional cancer indications - Neuroendocrine tumors (NET) and head and neck cancer. Both indications will be pursued with regard to both diagnostics and therapy meaning that Curasight strengthens its position as a theranostic company. With reference to the ...
By Curasight
-
New performance data for Accelerate Arc to be presented April 25 at ECCMID
Today we announced the release of new performance data across two studies for the Accelerate Arc module and BC kit at the 32nd European Congress for Clinical Microbiology and Infectious Diseases (ECCMID) located in Lisbon, Portugal 23-26 April 2022. Two posters featuring performance of the Accelerate Arc System will be presented on Monday April 25th, 12:00- 13:00 hr, Pavilion 3 of the Feira ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you